[Skip to Content]
JAMA Network Home
JAMA Cardiology
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:

New Online

Current Issue Past Issues

Year

Day

2017
October September August July June
October 18, 2017
Original Investigation

Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent ImplantationInsights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis

Wayne Batchelor, MD, MHS; David E. Kandzari, MD; Scott Davis, MD; et al.
Abstract Full Text
free access has audio
JAMA Cardiol. Published online October 18, 2017. doi:10.1001/jamacardio.2017.3802

This pooled analysis study examines 1-year outcomes in women and minorities vs white men following percutaneous coronary intervention with everolimus-eluting stents.

  • Audio Interview: Outcomes in Women and Minorities After Everolimus-Eluting Stent Implantation
Brief Report

Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private PayersInsights Derived From the FOURIER Trial

Alejandro Arrieta, PhD; Jonathan C. Hong, MD, MHS; Rohan Khera, MD; et al.
Abstract Full Text
JAMA Cardiol. Published online October 18, 2017. doi:10.1001/jamacardio.2017.3655

This study used a Markov decision model to determine the cost-effectiveness of a PCSK9 inhibitor and statin treatment strategy compared with a statin-alone strategy, using results of the FOURIER trial.

Feasibility, Process, and Outcomes of Cardiovascular Clinical Trial Data SharingA Reproduction Analysis of the SMART-AF Trial

Hawkins C. Gay, MD, MPH; Abigail S. Baldridge, MS; Mark D. Huffman, MD, MPH
Abstract Full Text
JAMA Cardiol. Published online October 18, 2017. doi:10.1001/jamacardio.2017.3808

This study evaluates the feasibility, process, and outcomes of a reproduction analysis of the SMART-AF trial using shared clinical trial data..

Editorial

Cost-effectiveness of PCSK9 InhibitorsProof in the Modeling

Robert O. Bonow, MD, MS; Robert A. Harrington, MD; Clyde W. Yancy, MD, MSc
Abstract Full Text
JAMA Cardiol. Published online October 18, 2017. doi:10.1001/jamacardio.2017.3656
JAMA Cardiology Clinical Challenge

A 52-Year-Old Man With Unheralded Syncope

Rishi K. Wadhera, MD, MPhil; Garrick C. Stewart, MD, MPH; Patrick T. O’Gara, MD
Abstract Full Text
JAMA Cardiol. Published online October 18, 2017. doi:10.1001/jamacardio.2017.2425

A 52-year-old man with mild asthma who experienced an episode of unheralded syncope while walking has sinus bradycardia and first-degree atrioventricular, left posterior fascicle, and right bundle branch blocks on electrocardiography. What is your diagnosis?

Editor's Note

Race/Ethnicity–Based Outcomes in Cardiovascular Medicine

Clyde W. Yancy, MD, MSc; Ajay J. Kirtane, MD, SM
Abstract Full Text
has audio
JAMA Cardiol. Published online October 18, 2017. doi:10.1001/jamacardio.2017.3826
  • Audio Interview: Outcomes in Women and Minorities After Everolimus-Eluting Stent Implantation
October 11, 2017
Original Investigation

Association of Mitochondrial DNA Copy Number With Cardiovascular Disease

Foram N. Ashar, PhD; Yiyi Zhang, PhD; Ryan J. Longchamps, BS; et al.
Abstract Full Text
JAMA Cardiol. Published online October 11, 2017. doi:10.1001/jamacardio.2017.3683

This cohort study determines whether mitochondrial DNA copy number, measured in an easy accessible tissue (buffy coat/circulating leukocytes), is associated with improved risk classification for cardiovascular disease and help guide initiation of statin therapy for primary prevention of cardiovascular disease.

Long-term Outcomes of Multiple Arterial Coronary Artery Bypass GraftingA Population-Based Study of Patients in British Columbia, Canada

Aihua Pu, MSc; Lillian Ding, MSc; Jungwon Shin, MSc; et al.
Abstract Full Text
JAMA Cardiol. Published online October 11, 2017. doi:10.1001/jamacardio.2017.3705

This population-based study compares the safety and long-term outcomes of multiple arterial grafting vs left internal thoracic artery supplemented by saphenous vein grafts among overall and selected subgroups of patients.

Brief Report

Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non–African American Women

Olga Corazón Irizarry, MD; Lisa D. Levine, MD, MSCE; Jennifer Lewey, MD, MPH; et al.
Abstract Full Text
JAMA Cardiol. Published online October 11, 2017. doi:10.1001/jamacardio.2017.3574

This cohort study compares the clinical characteristics, presentation, and outcomes of peripartum cardiomyopathy between African American and non–African American women.

Invited Commentary

Poor Outcomes in Poor Patients?Peripartum Cardiomyopathy—Not Just Black and White

Johann Bauersachs, MD
Abstract Full Text
JAMA Cardiol. Published online October 11, 2017. doi:10.1001/jamacardio.2017.3605

When Should Patients Be Involved in Cardiovascular Clinical Trial Design?Always, Early, and Often

Bray Patrick-Lake, MFS; Adrian F. Hernandez, MD, MHS
Abstract Full Text
JAMA Cardiol. Published online October 11, 2017. doi:10.1001/jamacardio.2017.3607
Special Communication

Incorporating Patient and Caregiver Experiences Into Cardiovascular Clinical Trial Design

Sean P. Collins, MD, MSc; Phillip D. Levy, MD, MPH; Jane L. Holl, MD, MPH; et al.
Abstract Full Text
JAMA Cardiol. Published online October 11, 2017. doi:10.1001/jamacardio.2017.3606

This article examines successful methods that have been used by researchers to engage patients, caregivers, and the broader health care community in the research process and offers examples of currently funded studies that have fully engaged key stakeholders.

Correction

Error in Conflicts of Interest Disclosures

Abstract Full Text
free access
JAMA Cardiol. Published online October 11, 2017. doi:10.1001/jamacardio.2017.3855
October 9, 2017
Editorial

Death by Gun Violence—A Public Health Crisis

Howard Bauchner, MD; Frederick P. Rivara, MD, MPH; Robert O. Bonow, MD, MS; et al.
Abstract Full Text
free access
JAMA Cardiol. Published online October 9, 2017. doi:10.1001/jamacardio.2017.4413
October 4, 2017
Original Investigation

Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations

Christopher B. Fordyce, MD, MHS, MSc; Carolina M. Hansen, MD, PhD; Kristian Kragholm, MD, PhD; et al.
Abstract Full Text
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.3471

This study describes temporal trends in bystander cardiopulmonary resuscitation and first-responder defibrillation for out-of-hospital cardiac arrests stratified by home vs public location and their association with survival and neurological outcomes.

From the Heart

Heart Failure Within the Federal Prison System

Ersilia M. DeFilippis, MD
Abstract Full Text
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.2857
Editorial

Improving Outcomes After Out-of-Hospital Cardiac Arrest

Terence Valenzuela, MD, MPH; Andrew J. Harrell, MD; Graham Nichol, MD, MPH
Abstract Full Text
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.3472
Comment & Response

Safety vs Efficacy of Lowering Blood Pressure

Chirag Bavishi, MD, MPH; Sripal Bangalore, MD, MHA; Franz H. Messerli, MD
Abstract Full Text
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.3534

Safety vs Efficacy of Lowering Blood Pressure

Jerzy Gąsowski, MD, PhD; Karolina Piotrowicz, MD, PhD; Tomasz Grodzicki, MD, PhD
Abstract Full Text
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.3537

Safety vs Efficacy of Lowering Blood Pressure—Reply

Clyde W Yancy, MD, MSc; Robert O. Bonow, MD, MS
Abstract Full Text
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.3540

Safety vs Efficacy of Lowering Blood Pressure—Reply

Joshua D. Bundy, MPH; Paul K. Whelton, MD; Jiang He, MD, PhD
Abstract Full Text
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.3543
Correction

Error in Byline

Abstract Full Text
free access
JAMA Cardiol. Published online October 4, 2017. doi:10.1001/jamacardio.2017.3763

Latest Issue

Highlights
In This Issue of JAMA Cardiology | October 1, 2017
Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
Original Investigation | October 1, 2017
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery StenosisA Systematic Review and Meta-analysis
Original Investigation | October 1, 2017
View More
×